Telesis Bio (TBIO) Competitors $0.90 0.00 (0.00%) As of 04/25/2025 02:48 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsTrendsBuy This Stock TBIO vs. TLIS, SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, and TTShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Talis Biomedical (TLIS), Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), and Trane Technologies (TT). These companies are all part of the "measuring and control equipment" industry. Telesis Bio vs. Talis Biomedical Schmitt Industries Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Telesis Bio (NASDAQ:TBIO) and Talis Biomedical (NASDAQ:TLIS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations, earnings and community ranking. Is TBIO or TLIS more profitable? Talis Biomedical has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Telesis Bio's return on equity of 0.00% beat Talis Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Telesis Bio-336.59% N/A -61.89% Talis Biomedical N/A -79.74%-57.16% Do insiders and institutionals believe in TBIO or TLIS? 37.6% of Telesis Bio shares are held by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are held by institutional investors. 24.5% of Telesis Bio shares are held by company insiders. Comparatively, 46.0% of Talis Biomedical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, TBIO or TLIS? Telesis Bio has higher revenue and earnings than Talis Biomedical. Talis Biomedical is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelesis Bio$225.09M0.01-$47.72M-$28.20-0.03Talis Biomedical$300K9.72-$62.01M-$28.02-0.06 Does the MarketBeat Community believe in TBIO or TLIS? Telesis Bio and Talis Biomedical both received 9 outperform votes by MarketBeat users. However, 52.94% of users gave Telesis Bio an outperform vote while only 37.50% of users gave Talis Biomedical an outperform vote. CompanyUnderperformOutperformTelesis BioOutperform Votes952.94% Underperform Votes847.06% Talis BiomedicalOutperform Votes937.50% Underperform Votes1562.50% Which has more risk and volatility, TBIO or TLIS? Telesis Bio has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. Does the media favor TBIO or TLIS? In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Talis Biomedical'saverage media sentiment score. Company Overall Sentiment Telesis Bio Neutral Talis Biomedical Neutral SummaryTelesis Bio and Talis Biomedical tied by winning 6 of the 12 factors compared between the two stocks. Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.62M$4.12B$5.44B$7.80BDividend YieldN/A0.60%5.43%4.31%P/E Ratio-0.0326.9622.1418.40Price / Sales0.014.21389.71101.29Price / CashN/A36.1138.2034.62Price / Book6.431.766.664.18Net Income-$47.72M-$83.57M$3.21B$247.71M7 Day Performance-2.34%3.08%6.21%6.61%1 Month Performance200.00%-0.21%-2.82%-2.21%1 Year Performance-84.30%-32.19%16.44%4.68% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis BioN/A$0.90flatN/A-84.9%$1.62M$225.09M-0.03200Gap DownTLISTalis BiomedicalN/A$1.60-5.9%N/A-82.0%$2.92M$300,000.00-0.06260Gap DownSMITSchmitt IndustriesN/A$0.02flatN/AN/A$72,000.00$9.89M0.00160SPECSpectaireN/A$0.00flatN/A-99.8%$20,000.00N/A0.008THMOThermoGenesisN/A$0.00-85.7%N/A-100.0%$1,000.00$9.61M0.0040Gap DownHTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.04-13.9%N/A-75.1%$0.00N/A0.003Gap DownHigh Trading VolumePRENWPrenetics GlobalN/A$0.01+2.0%N/A+19.0%$0.00$25.56M0.001Negative NewsGap DownQSIAWQuantum-SiN/A$0.35+4.5%N/A+72.7%$0.00$3.06M0.00150Gap UpSMAPWSportsMap Tech AcquisitionN/A$0.06-8.0%N/AN/A$0.00N/A0.00N/ATTTrane Technologies4.4994 of 5 stars$322.29-3.3%$405.31+25.8%+16.3%$72.29B$19.84B28.6539,000Upcoming EarningsAnalyst UpgradeNews CoveragePositive News Related Companies and Tools Related Companies Talis Biomedical Competitors Schmitt Industries Competitors Spectaire Competitors ThermoGenesis Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TBIO) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TBIO Stock Free TBIO Stock Alerts